Higher net result than 89% of companies in retail trade. Sector median €4,757 · 25,309 companies.
2025 accounts filed 4 days after the deadline
Checked score
Checked score
The higher the Checked score (0 to 100), the smaller the chance that the company goes bankrupt within twelve months. That chance sets the band, from Critical to Excellent, and within the band how the company does against its sector peers counts too. With a low score, agree a shorter payment term, an advance or security.
XXVisible after signing in
HiddenVisible after signing in
Bankruptcy probability within 12 months
Bankruptcy probability
It is the chance that the company goes bankrupt within twelve months, estimated from the registers, the annual accounts and the Belgian Official Gazette. At 0.2%, about 2 in 1,000 comparable companies go bankrupt. The higher it is, the shorter the payment term to agree.
XXVisible after signing in
Financial strength
Financial strength
Financial strength measures the balance sheet and the results with three figures out of 100 from the latest annual accounts: solvency, liquidity and profitability. It does not directly set the Checked score's band. How the company does against its sector peers on these and on growth does count for its place within the band.
XXVisible after signing in
XXVisible after signing in
XXVisible after signing in
Score breakdown
Visible after signing inVisible after signing in
Comparable companies, two years later
In July 2024, 7,984 companies had the same profile as Apotheek Van den Bergh has now. Each dot stands for 20 companies, two years later.
94.2%
were still trading
1.9%
stopped another way
3.6%
went bankrupt
Micro
2 to 5 years old
solvency 10 to 30%
a profit of 5% of the balance sheet or more
Another 0.3% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,962 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
The companies in ten equal groups, from the lowest to the highest expected share
Group
Expected
Actual
1
0.2%
0.2%
2
0.3%
0.5%
3
0.5%
0.6%
4
0.7%
0.8%
5
0.9%
0.9%
6
1.3%
1.5%
7
1.6%
1.8%
8
1.8%
1.8%
9
2.9%
3.1%
10
5.6%
6.1%
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 7,984 companies, not a prediction for Apotheek Van den Bergh. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit verdict
The credit verdict says how much credit you can give the company on open account. “Acceptable” means normal terms, “With conditions” means limiting the amount or the term. “Not advised” means asking for payment up front.
Visible after signing inVisible after signing in
Credit check for an amount and term of your choice
Registered in the Peppol Directory
Reachable for e-invoices through 0208:1009186713
Incorporation
Founding capital of €6,000, 1,000 shares · Founded by Hidden nameVisible after signing in · Name after signing inVisible after signing in appointed as director · published on 10-05-2024 · Gazette deed
Sector peers are the companies with the same activity (NACE code) and, where stated, the same size, that the company is compared with. A percentile says how many of them do worse.
These companies have the same main activity as Apotheek Van den Bergh: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €486,000 and €651,000, founded between 2024 and 2025.
Apotheek Van den Bergh has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €71,644 and a net result of €53,712.
Its solvency ranks better than 33% of 25,338 sector peers (NACE 47) in financial year 2025.
What is the company number of Apotheek Van den Bergh?
The company number of Apotheek Van den Bergh is 1009.186.713. The VAT number is the same number with BE in front: BE 1009.186.713.
Where is Apotheek Van den Bergh based?
The registered office is at Molenstraat 9, 2550 Kontich.Company details
What does Apotheek Van den Bergh do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of Apotheek Van den Bergh?
Apotheek Van den Bergh is a private limited company (BV).
When was Apotheek Van den Bergh founded?
Apotheek Van den Bergh was founded on 07-05-2024.
Is Apotheek Van den Bergh still active?
Yes, Apotheek Van den Bergh is an active enterprise in the KBO register.
How many employees does Apotheek Van den Bergh have?
Apotheek Van den Bergh had an average of 1 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does Apotheek Van den Bergh fall under?
In its 2025 annual accounts, Apotheek Van den Bergh states joint committee 313 (Pharmacies and pricing offices).
What is the turnover of Apotheek Van den Bergh?
The turnover in financial year 2025 is ≈ €650,000. This figure is estimated from the gross margin of €184,631 and 38 comparable companies (NACE 477). It probably lies between €490,000 and €1.1m.
Is Apotheek Van den Bergh profitable?
In financial year 2025, Apotheek Van den Bergh made a profit of €53,712.
Where can I find the annual accounts of Apotheek Van den Bergh?
Apotheek Van den Bergh filed 2 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Apotheek Van den Bergh due?
Apotheek Van den Bergh must file the annual accounts for financial year 2026 by 31-07-2027.Timeline